𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝗶𝘀 𝗖𝗵𝗶𝗹𝗱𝗵𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵.

Globally, approximately 400,000 children and adolescents are diagnosed with cancer each year, and every family’s life is changed forever by that diagnosis. Many countries have seen major survival improvements, but outcomes remain uneven: survival rates differ widely between and within regions, and millions of children still lack timely access to specialised paediatric oncology care, clinical trials and child-appropriate treatments. Low- and middle-income countries carry the largest burden of mortality, while high-income countries struggle with gaps in access to the latest innovations and long-term follow-up for survivors.

To improve outcomes worldwide we need more and smarter investment in childhood-cancer research, faster development and fair global access to affordable, child-specific medicines, and stronger health systems that provide standardised multidisciplinary care, early diagnosis and survivorship services. Policymakers, funders, clinicians, researchers, patient groups and communities must collaborate to close disparities — you can help by supporting trusted childhood-cancer charities, advocating for equitable research funding and care policies, and sharing verified information and survivor stories with consent.

#ChildhoodCancerAwareness #GlobalHealth #PaediatricOncology #KidsCancer #ChildhoodCancerResearch #SurvivorCare #HealthEquity #FundResearch #EarlyDiagnosis #ClinicalTrials #SupportFamilies #CureMoreCureBetter #SCABPharmacy